Can-Fite Biopharma Ltd (CANF) vs Jaguar Animal Health, Inc. (JAGX)
- Can-Fite Biopharma Ltd CANF 1.47 −2.65%
- Jaguar Animal Health, Inc. JAGX 0.32 −8.57%
Can-Fite Biopharma Ltd and Jaguar Animal Health, Inc. are both Biotechnology companies. Can-Fite Biopharma Ltd and Jaguar Animal Health, Inc. are of similar size ($4.7M and $4.6M). Can-Fite Biopharma Ltd has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 129.7% against −3.36%. Jaguar Animal Health, Inc. has the higher net margin (−181.8% vs −1,148.6%) and the lower return on invested capital (−117.8% vs 0.00%). Across the 18 metrics below, Jaguar Animal Health, Inc. leads on 11 and Can-Fite Biopharma Ltd on 7.
Valuation
Profitability
| Metric | CANF | JAGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 81.47% | 70.18% |
| Operating margin | 0.00% | (91.15%) | 0.00% |
| Net margin | (1,148.62%) | (181.84%) | 0.00% |
| Free cash flow margin | 0.00% | (25.58%) | 0.00% |
| Return on equity | 0.00% | (480.38%) | (51.58%) |
| Return on assets | 0.00% | (120.10%) | (45.91%) |
| Return on invested capital | 0.00% | (117.79%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack